Marc Ditmarsch
Former Country Medical Director - Astrazeneca
Sessions
-
Wednesday - May 13, 2020 - 10:50
Case Study: The role of surrogate markers in (cardiovascular) drug development
The session will highlight the importance of surrogate markers in general for drug development and in the field of cardiovascular research in particular. Following aspects will be covered in the presentation:
- Inform / de-risk phase III
- Proof of Concept
- Enrich patient population
- Label enhancement
Stay Informed
Subscribe today to receive news on latest updates,
offers and upcoming conferences via email
follow us
Follow us online to stay up to date about our conferences
For general conference and registration enquires please contact the below email id or fill out the form
info@corvusglobalevents.com
+44 (0) 207 096
0786
Experience the power of community building
Comprehensive Event Listings
Swift Event Registration
Enhanced Networking Opportunities
In-App Chat Feature
Schedule Meetings
Interactive session participation
Real-time event updates and notifications
Feedback and survey tools
Badge Scanning
Robust security and data protection
Continuous Connectivity for long-term professional relationships
